Paul Reider

CHRS

Paul Reider serves as Chief Commercial Officer at Coherus Oncology, Inc. (CHRS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$3.8K

Net Position

Net Seller

$3.8K

Companies Traded

CHRS

Active Period

Jan 2025

1 total trades

Most Recent

Sell CHRS

Jan 3, 2025 · $3.8K

Paul Reider's Insider Trading at Coherus Oncology, Inc. (CHRS)

Buys

0 · $0.00

Sells

1 · $3.8K

Total Shares Bought

Total Shares Sold

2,277

CHRS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 3, 2025	Sell	2,277	$1.66	$3.8K	0

Explore More Insider Trading Data

CHRS Insider Trading Activity

View all insider trades at Coherus Oncology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity